Updated:
Healthy.io Ltd
Healthy.io transforms the smartphone camera into a clinical-grade medical device using colorimetric analysis, computer vision, and AI. The company offers...
Healthy.io Ltd
Healthy.io transforms the smartphone camera into a clinical-grade medical device using colorimetric analysis, computer vision, and AI. The company offers FDA-cleared home urinalysis for kidney testing and digitized wound care management. Its technology integrates with existing EMR systems to help health systems and providers close care gaps and improve patient access.
General information
Firm type
other
Location
Region
Middle East
Country
Israel
City
Tel Aviv-Yafo
Corporate office
Tel Aviv-Yafo, Israel
Principals
Dr. Setu Vora
Pequot Tribal Chief Medical Officer
Sector focus
Frequently asked questions
How does Healthy.io source proprietary deal flow?
Healthy.io operates as a healthcare technology company, not a family office or investment vehicle. Its partnerships stem from direct relationships with health insurers and provider networks — such as Blue Cross of Idaho and Medica — rather than traditional deal sourcing (per firm website).
Does Healthy.io participate in fund commitments or only direct deals?
Healthy.io does not make investments. It is an operating company that raises capital from investors and generates revenue through contracts with health plans and health systems. No fund or investment vehicle exists (Altss research).
What investment stages does Healthy.io typically target?
Healthy.io is not an investment entity and does not target investment stages. Its business stages are commercial and clinical: product development, regulatory clearance, and partnership deployment (Altss research).
Which sectors does Healthy.io explicitly avoid?
Healthy.io does not publish investment restrictions. As a diagnostics company, it focuses on chronic disease areas (kidney disease, wound care) and does not engage in other sectors like real estate or private equity (Altss research).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: